000 01109 a2200313 4500
005 20250517095026.0
264 0 _c20170705
008 201707s 0 0 eng d
022 _a1750-7448
024 7 _a10.2217/imt-2016-0013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPaul, Barry
245 0 0 _aCheckpoint inhibition for colorectal cancer: progress and possibilities.
_h[electronic resource]
260 _bImmunotherapy
_c06 2016
300 _a693-704 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBiomarkers, Pharmacological
_xmetabolism
650 0 4 _aColorectal Neoplasms
_xdiagnosis
650 0 4 _aCostimulatory and Inhibitory T-Cell Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aPrognosis
700 1 _aO'Neil, Bert H
700 1 _aMcRee, Autumn J
773 0 _tImmunotherapy
_gvol. 8
_gno. 6
_gp. 693-704
856 4 0 _uhttps://doi.org/10.2217/imt-2016-0013
_zAvailable from publisher's website
999 _c26036667
_d26036667